Lifeward Ltd. (LFWD) Enterprise Value to EBITDA Ratio
The integration of exoskeletons into clinics creates a sustainable dependence of staff on the equipment, providing ReWalk Robotics Ltd. (LFWD) with a stable stream of service revenue. The historical EV/EBITDA price trend is currently at 0.00. However, high system costs and complexities regarding insurance payouts are hindering sales. Slow approval for home devices in the US is forcing management to strictly limit promotional spending to achieve operating profit.
Comprehensive metric breakdowns and analytics for rewalk.com (LFWD)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
LFWD - Net Financial Result|Projected Future Earnings ReWalk Robotics Ltd.|LFWD - Price to Earnings Ratio|Forward P/E Multiple ReWalk Robotics Ltd.|LFWD - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lifeward Ltd.|LFWD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Lifeward|LFWD - Earnings per share for the trailing year|Quarterly EPS earnings growth rewalk.com|LFWD - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year ReWalk Robotics Ltd.
Analysis of all company metrics:ReWalk Robotics Ltd LFWD
The stable moat of ReWalk Robotics Ltd. (LFWD) in the exoskeleton niche, secured by patents, makes the EV/EBITDA multiple a key tool for valuing the business while accounting for net debt. This indicator compares the total enterprise value with operating profit before taxes, allowing for the identification of the asset's fundamental floor. Analysis of this chart helps distinguish a temporary market shock from a systemic decline in capital efficiency.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VANI (Vivani Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xtant Medical Holdings, Inc.|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corp. (NMTC)|EV/EBITDA Multiple MODD|MYO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envoy Medical COCH|VVOS: Enterprise Value to Operating Income Before Depreciation|NVNO: Enterprise Value to EBITDA Ratio|Sintx Technologies - Enterprise Value to Operating Income Before Depreciation Ratio|Tenon Medical, Inc. (TNON) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Autonomix Medical - Business Value to Operating Income Before Depreciation|IVF (INVO Fertility) - EV/EBITDA Multiple|Company Value to EBITDA Bone Biologics Corp. BBLG|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|Enterprise Value to EBITDA Ratio Biolase Inc. BIOL|EV/EBITDA Multiple DYNT (Dynatronics)|EV/EBITDA Multiple Paragon 28 Inc. FNA|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
